This result, together with the correlation between MMP-2 levels and kPa, FIB-4, aminotransferases and sCD163, suggests that MMP-2 may be used as a marker of established hepatic fibrosis, both in mHCV and HIV/HCV patients. The gene discussed is CD163; the disease is Hepatic fibrosis.